PSMA-targeted contrast agents for intraoperative imaging of prostate cancer
Posted by
Jeong Heon Lee
on 2019-09-12
Prostate-specific membrane antigen (PSMA) can serve as a molecular cell surface target for the detection and treatment of prostate cancer. Near-infrared (NIR) fluorescence imaging enables highly sensitive, rapid, and non-radioactive imaging of PSMA, though specific targeting still remains a challenge because no optimized contrast agents exist.
Related content
29 08 2024
< 1 minute
euroSAMPL1 blind prediction challenge with Chemaxon's Calculators and Predictors
euroSAMPL1 blind prediction challenge - using calculators and predictors by Chemaxon
19 04 2023
< 1 minute
Predicting pKa
One of the most important physicochemical properties of small molecules and macromolecules are the...
03 10 2022
< 1 minute
Calculate on the cloud
In order to increase the flexibility, access and integrability, Calculators and Predictors have...
12 05 2022
< 1 minute
Coupling stabilizers open KV1-type potassium channels
ABSTRACT: The opening and closing of voltage-gated ion channels are regulated by voltage sensors...